I would like your opinion on the role of corticosteroids in early and late ARDS. When should I institute steroids in my patient with ARDS? The complexities of the ARDSnet study and the variation seen ...

A team of international scientists have recently estimated the risk and prevalence of acute respiratory distress syndrome (ARDS) in hospitalized young adults with severe acute respiratory syndrome ...

Early driving pressure trajectories in patients with COVID-19 ARDS are independently associated with the risk for prolonged mechanical ventilation.

Breathing troubles can feel frightening, especially when the cause is serious. Among the many lung conditions, two names that often come up are pneumonia and Acute Respiratory Distress Syndrome (ARDS) ...

Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...

Please provide your email address to receive an email when new articles are posted on . Researchers have identified two new distinct subphenotypes of adults with acute respiratory distress syndrome, ...

HONOLULU — Patients with acute respiratory distress syndrome (ARDS) and coexisting pulmonary hypertension (PH) are significantly more likely to have longer and more costly hospital stays and to die in ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension plus acute respiratory distress syndrome resulted in poor hospital outcomes. Odds for ...

Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome (ARDS) resulting from severe COVID ...

Q1 2026 Management View Dr. Jennifer Buell (Co-Founder, President, CEO & Director) framed recent disclosures around clinical and mechanistic readouts across oncology and pulmonary indications, saying, ...

Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight The ARSD clinical trial analysis report delivers important ...